Search clinical trials for: Sumatriptan Succinate

Total 515 results

Sorrento Therapeutics, Inc.
Kimberly-Clark Corporation

Completed

Sofusa System With Sumatriptan (KC5010) Phase 1 Dose Escalation Safety and PK Study (KCC-SMT-002) (KCC-SMT-002)

Migraine Disorders

United States
NuPathe Inc.

Completed

Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®

Healthy

United States
GlaxoSmithKline

Completed

Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan

Migraine Disorders

Japan
NuPathe Inc.

Completed

Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy Adults

Compare Bioequivalence Patches Previously Used in the NP101-007 Study

United States
Charleston Laboratories, Inc

Completed

A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain

Pain | Nausea | Vomiting | Migraine | Aura

United States
Dr. Reddy's Laboratories Limited

Completed

Pilot Study of Two Different Strengths of DFN-11 Injection for Rapidly Escalating Migraine

Rapidly Escalating Migraine

United States
Pfizer

Completed

A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack

Migraine

United States
Teva Pharmaceuticals USA

Completed

Sumatriptan Succinate 100 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Sumatriptan Succinate 100 mg Tablets Under Non-Fasting Conditions

Healthy

United States
NuPathe Inc.

Completed

Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period (NP101-011)

Migraine Disorders

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg

Healthy

United States
NeurAxon Inc.

Completed

Study of NXN 188 for the Treatment of Migraine With Aura

Migraine With Aura

United States
GlaxoSmithKline

Completed

Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents

Migraine Disorders

United States
Changchun Huayang High-tech Co., Ltd
Beijing Bionovo Medicine Development Co., Ltd.

Unknown

Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease

Alzheimer's Disease

China
GlaxoSmithKline

Completed

TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1)

Migraine, Without Aura

United States
GlaxoSmithKline

Completed

Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks

Migraine Disorders

United States
GlaxoSmithKline

Completed

Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents

Migraine Disorders

Japan
GlaxoSmithKline

Completed

Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA)

Migraine | Migraine Disorders

United States
GlaxoSmithKline

Completed

Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks

Migraine | Migraine Disorders

United States
Hutchison Medipharma Limited

Unknown

HMPL-813 in Treating Patients With Glioblastoma

Glioblastoma

China
Bial - Portela C S.A.
Covance

Completed

Effect of BIA 5 1058 on Cardiac Repolarization

Heart Failure | Cardiovascular Disease | Pulmonary Arterial Hypertension

United Kingdom
Merck Sharp & Dohme LLC

Completed

Study to Evaluate the Safety, Tolerability, and Blood Pressure Effect of an Oral Dose of Sumatriptan Alone and in Combination With MK-0974 (Telcagepant) in Migraine Patients (0974-026)

Migraine Disorders
Upsher-Smith Laboratories

Completed

An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg)

Migraine Headaches

United States
GlaxoSmithKline

Completed

A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)

Migraine Disorders

United States
GlaxoSmithKline

Completed

A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2)

Migraine Disorders

United States
GlaxoSmithKline

Completed

Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea

Migraine Disorders

United States
Cady, Roger, M.D.
GlaxoSmithKline

Completed

"Completeness of Response" Following Treatment With Treximet™ for Migraine

Migraine

United States
Organon and Co

Completed

Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030)

Migraine Headache
Cambridge University Hospitals NHS Foundation Trust

Unknown

Sumatriptan and Glucose

Overweight

United Kingdom
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo

Migraine With or Without Aura
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack Study

Migraine With or Without Aura
Avanir Pharmaceuticals

Completed

Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without Aura (COMPASS)

Migraine | Headaches

United States
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

Clinical Trial of Trelagliptin Succinate Tablets in the Treatment of Type 2 Diabetes

Diabetes Mellitus, Type 2

China
Shanghai Fosun Pharmaceutical Industrial Development...

Recruiting

A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients

Advanced Solid Tumor | Advanced Cancer | Lung Cancer, Nonsmall Cell

China
Danish Headache Center
Bispebjerg Hospital; Glostrup University Hospital, Copenhagen

Completed

Neuropeptides in the Humane Intra- og Extracerebral Circulation.

Healthy | Migraine

Denmark
GlaxoSmithKline

Completed

TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine

Migraine Disorders

United States
Neurological Research Center
GlaxoSmithKline

Unknown

Treximet in Acute Migraine Headache: Assessing Cognitive Function

Cognitive Impairment | Migraine Headache

United States
Zogenix, Inc.

Completed

A Study on the Usability of the Needle-free Intraject® System in Adult Patients During Acute Migraine Attack

Migraine Headache

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Sumatriptan 100mg Tablets Under Fed Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Sumatriptan 100mg Tablets Under Fasting Conditions

Healthy

India
Damanhour Teaching Hospital

Completed

Is Theophylline More Effective Than Sumatriptan in the Treatment of Post-dural Puncture Headache

Post-Dural Puncture Headache

Egypt
Astellas Pharma Inc

Completed

Relative Bioavailability Study of Solifenacin Succinate Liquid Suspension (Fed and Fasting) Versus VESIcare Tablet (Fasting) in Healthy Volunteers

Healthy Volunteers | Pharmacokinetics of Solifenacin Succinate | Bioavailability of Solifenacin Succinate

United States
Diamond Headache Clinic
GlaxoSmithKline

Unknown

Sumatriptan 4 mg Statdose in the Acute Treatment of Cluster Headache

Episodic Cluster Headache | Chronic Cluster Headache

United States
Huashan Hospital

Completed

the Efficacy and Safety of Vitamin C for Iron Supplementation in Adult IDA Patients

Anemia, Iron-Deficiency

China
Astellas Pharma Inc

Completed

Single-dose Study to Assess Pharmacokinetics of Solifenacin Succinate Suspension in Children and Adolescents

Urinary Bladder, Overactive

Sweden, United Kingdom, Belgium, Denmark
Astellas Pharma Europe B.V.

Completed

A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO)

Pediatric | Neurogenic Detrusor Overactivity

United States, Belgium, Korea, Republic of, Philippines, Poland, United Kingdom
Astellas Pharma Europe B.V.

Completed

A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076 (LEOPARD)

Urinary Bladder, Overactive

Belgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
Center Eugene Marquis

Terminated

Solifenacin Succinate for Treatment of Urinary Toxicity Occurring During Radiotherapy of Prostatic Cancer (VesiCaP)

Overactive Bladder

France
NuPathe Inc.

Completed

Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers (NP101-006)

Migraine Disorders

United States

3

Subscribe